Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
基本信息
- 批准号:10673933
- 负责人:
- 金额:$ 288.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAccelerationAction ResearchAddressAdvocateAffectAfrican AmericanAfrican American populationAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaAutopsyAwarenessBiological MarkersBiological Specimen BanksBloodBrainBrain imagingCaringClinicClinicalClinical ResearchClinical TrialsClinical Trials Support UnitCollaborationsCommunitiesComplementDNADataData ScientistDedicationsDementiaDevelopmentDiseaseDisparityEarly identificationEducationFacultyFamily CaregiverFosteringFoundationsFundingGeneticGoalsGrantHealth ProfessionalHeterogeneityImageIndividualIndividual DifferencesInstitutionInterventionLeadershipLinkMemoryOutcomeParticipantPathogenicityPersonal SatisfactionPilot ProjectsPlasmaPlayPreventionProteinsProteomicsPublic HealthPublicationsRaceRecommendationResearchResearch ActivityResearch PersonnelResearch SupportResourcesRiskRisk FactorsRoleSamplingScientistSpecial PopulationSpecimenSpinal CordTeacher Professional DevelopmentTrainingTranslatingTranslational ResearchTranslationsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVariantWorkbasebuilt environmentburden of illnesscaregivingcaregiving researchclinical practicecohortcommunity partnershipdata managementdesigndiversity and inclusioneducation researcheffective therapyempowermentethnoracialfaculty mentorhealthy agingimprovedinnovationmemory careminority engagementmultidisciplinaryneuropathologynext generationnoveloutreachprogramsrecruitresearch studyresponsesuccesssupportive environmentsymposiumtherapeutic targettraining opportunity
项目摘要
SUMMARY/ABSTRACT: OVERALL
The Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory University provides Georgia and the
region with comprehensive clinical, research, and educational programs. This application outlines our success
in building an environment that encourages and supports innovative projects with a central theme of discovery
and translation of new biomarkers and pathogenic mechanisms to enable early identification, intervention, and
ultimately prevention of AD and related disorders. Given the well documented disparities in clinical research
participation and burden of disease for AD in the African American community, the Goizueta ADRC dedicates
effort and resources to help better understand and address inter-individual differences in AD and ADRD,
ranging from ethno-racial factors to individual differences in genetic and protein variation. We benefit from
generous institutional support from Emory, one of the nation’s fastest growing research academic medical
centers, the generous Atlanta community, and a large and highly collaborative interdisciplinary team of more
than 100 faculty across Emory and local institutions. Our cores work in a concerted manner to effectively
recruit, evaluate, and engage a diverse cohort of participants who actively take part in a wide variety of
research studies. The addition of a Minority Engagement Core helps to further engage special populations,
most notably the African American community, to help the Outreach, Recruitment and Engagement Core and
Clinical Core with an ambitious goal of 50% African American participation in the UDS cohort. Our Biomarker
Core provides state-of-the-art genetic, proteomic, and brain imaging analyses, complemented by an extensive
biospecimen repository of well-characterized blood, CSF, and DNA samples, and a large bank of well-
characterized postmortem brains and spinal cords in the Neuropathology Core. These valuable resources will
continue to be distributed widely for a variety of approved studies, including research Developmental Projects
and in support of local and national collaborations. Generous institutional and philanthropic support is used to
seed a much larger base of innovative research. The ADRC educational programs reach a broad audience of
trainees, researchers, health care professionals, and the public. New to us with this application, the Research
Education Component will help formalize our longstanding dedication to the cultivation of the next generation
of scientists. With a strong commitment to diversity and inclusiveness, our program benefits from the
engagement of a large and multidisciplinary core of training faculty mentors from institutions throughout the
greater Atlanta area. Collectively, the ADRC is poised to continue to make important contributions to the
national strategy for AD treatment and prevention.
摘要/摘要:总体
埃默里大学戈伊苏埃塔阿尔茨海默病研究中心 (ADRC) 为佐治亚州和
该应用程序概述了我们的成功。
建立一个鼓励和支持以发现为中心主题的创新项目的环境
和翻译新的生物标志物和致病机制,以实现早期识别、干预和治疗
鉴于临床研究中有充分记录的差异,最终预防 AD 和相关疾病。
戈伊苏埃塔 ADRC 致力于非裔美国人社区 AD 的参与和疾病负担
努力和资源帮助更好地理解和解决 AD 和 ADRD 的个体差异,
从民族种族因素到遗传和蛋白质变异的个体差异,我们都受益匪浅。
来自埃默里大学的慷慨机构支持,埃默里大学是美国发展最快的研究学术医学之一
中心、慷慨的亚特兰大社区,以及一个由更多人组成的大型且高度协作的跨学科团队
埃默里大学和当地机构的 100 多名核心教师齐心协力,高效工作。
招募、评估和吸引积极参与各种活动的多元化参与者
少数族裔参与核心的增加有助于进一步吸引特殊人群,
最值得注意的是非裔美国人社区,以帮助外展、招聘和参与核心和
临床核心的雄心勃勃的目标是 50% 的非裔美国人参与 UDS 队列。
Core 提供最先进的遗传、蛋白质组和脑成像分析,并辅以广泛的
生物样本库,包含经过充分表征的血液、脑脊液和 DNA 样本,以及大量经过充分鉴定的样本
这些宝贵的资源将在神经病理学核心中描述死后大脑和脊髓的特征。
继续广泛分发用于各种批准的研究,包括研究开发项目
并支持地方和国家合作。
ADRC 教育项目覆盖更广泛的受众。
受训者、研究人员、医疗保健专业人员和公众对我们来说是新的应用程序,即研究。
教育部分将有助于正式化我们对培养下一代的长期奉献
凭借对多样性和包容性的坚定承诺,我们的计划受益于
来自世界各地各机构的大型、多学科培训教师导师的核心参与
总的来说,ADRC 准备继续为大亚特兰大地区做出重要贡献。
AD 治疗和预防国家战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALLAN I LEVEY其他文献
ALLAN I LEVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALLAN I LEVEY', 18)}}的其他基金
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
路易体痴呆皮质边缘病理生理学的新型蛋白质生物标志物
- 批准号:
10514142 - 财政年份:2022
- 资助金额:
$ 288.47万 - 项目类别:
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
路易体痴呆皮质边缘病理生理学的新型蛋白质生物标志物
- 批准号:
10704614 - 财政年份:2022
- 资助金额:
$ 288.47万 - 项目类别:
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
路易体痴呆皮质边缘病理生理学的新型蛋白质生物标志物
- 批准号:
10704614 - 财政年份:2022
- 资助金额:
$ 288.47万 - 项目类别:
相似国自然基金
基于增广拉格朗日函数的加速分裂算法及其应用研究
- 批准号:12371300
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
肠菌源性丁酸上调IL-22促进肠干细胞增殖加速放射性肠损伤修复的机制研究
- 批准号:82304065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肌红蛋白构象及其氧化还原体系探究tt-DDE加速生鲜牛肉肉色劣变的分子机制
- 批准号:32372384
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于联邦学习自动超参调整的数据流通赋能加速研究
- 批准号:62302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
M2 TAMs分泌的OGT通过促进糖酵解过程加速肝细胞癌恶性生物学行为的机制研究
- 批准号:82360529
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Development of A Dual Chemokine CCL2/CCL5 Neutralizing Single-domainAntibody for Treating Non-alcoholic Steatohepatitis
双趋化因子 CCL2/CCL5 中和单域抗体的开发用于治疗非酒精性脂肪性肝炎
- 批准号:
10761039 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
Probing the link between sensory systems and metabolism to prevent obesity
探索感觉系统和新陈代谢之间的联系以预防肥胖
- 批准号:
10659964 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
Autonomic Dysfunction in Patients with HFpEF
HFpEF 患者的自主神经功能障碍
- 批准号:
10587484 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
ENABLING SUBMILLISECOND-TIMESCALE TWO-PHOTON RECORDING OF VOLTAGE DYNAMICS IN THREE DIMENSIONS IN VIVO
实现体内三维电压动态的亚毫秒级双光子记录
- 批准号:
10739579 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
Contributions of autophagy-related genes in lupus
自噬相关基因在狼疮中的贡献
- 批准号:
10682136 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别: